News Moderna to relocate its UK HQ to London's Tribeca Moderna has firmed up its commitment to the UK by taking a lease on a new headquarters at Tribeca, in the heart of the London Knowledge Quarter.
News Moderna, Oxford Uni Ebola jabs backed for pivotal testing Two more Ebola vaccines are set to be added to a trial in the Democratic Republic of the Congo (DRC), currently battling its largest-ever outbreak.
News ESMO26: Moderna, MSD reveal cancer jab data early after leak Moderna and MSD shared the results for their melanoma cancer vaccine trial, ahead of a presentation at ESMO tomorrow, after a data breach.
News FDA approves new COVID shots - with same restrictions as las... FDA has approved the 2026 COVID vaccine formulations, but last year's narrower recommendation stands, leaving open questions about access.
News MSD, Moderna skin cancer vaccine scores historic phase 3 win Strong phase 3 results for Moderna's individualised skin cancer vaccine could pave the way for a leap forward in the field.
News FDA clears Moderna's mRNA-based seasonal flu shot After a series of regulatory twists and turns, the FDA has approved Moderna's mRNA-based influenza vaccine mFlusiva.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.